Biologics: Targets and Therapy

SJR Rank #4,981H-index: 53SJR: 0.989Best quartile: Q1Open AccessAPC: US$2,320Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Dove Medical Press Ltd

Country

New Zealand

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • GastroenterologyQ1
  • Pharmacology (medical)Q1
  • Immunology and AllergyQ2
  • OncologyQ2
  • RheumatologyQ2

Areas: Medicine

Most published research topics

Rheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and PathogenesisMonoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical MethodsSystemic Lupus Erythematosus ResearchSpondyloarthritis Studies and TreatmentsInflammatory Bowel DiseaseChronic Lymphocytic Leukemia ResearchLung Cancer Treatments and MutationsAutoimmune and Inflammatory Disorders Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs020406080

Documents per Year

20222025015304560

Detailed Information

ISSN

1177-5491, 1177-5475

SJR Best Quartile

Q1

Region

Pacific Region

Citations per Document (2 years)

4.37

References per Document

55.50

Coverage

1988, 2007-2026

Scope

An international, peer-reviewed journal focusing on the patho-physiological rationale for and clinical application of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.

Metrics from SCImago Journal Rank 2025. View on SCImago